{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:32:39Z","timestamp":1715959959374},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,8,1]],"date-time":"1990-08-01T00:00:00Z","timestamp":649468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1990,8]]},"DOI":"10.1007\/bf00167062","type":"journal-article","created":{"date-parts":[[2004,11,6]],"date-time":"2004-11-06T05:46:02Z","timestamp":1099719962000},"page":"1-8","source":"Crossref","is-referenced-by-count":17,"title":["Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine"],"prefix":"10.1007","volume":"9","author":[{"given":"Justin D.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ian","family":"Robins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manucher J.","family":"Javid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.1988.68.1.0001","volume":"68","author":"PL Kornblith","year":"1988","unstructured":"Kornblith PL, Walker MD: Chemotherapy for malignant gliomas. J Neurosurg 68: 1?17, 1988","journal-title":"J Neurosurg"},{"key":"CR2","first-page":"1437","volume-title":"Cancer Principles and Practice of Oncology","author":"PL Kornblith","year":"1985","unstructured":"Kornblith PL, Walker MD, Cassady JR: Neoplasms of the central nervous system. In: DeVita VT, Hellman S and Rosenberg SA (eds) Cancer Principles and Practice of Oncology, 2nd edition. J.B. Lippincott, Philadelphia, 1985, pp 1437?1622","edition":"2nd edition"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(87)90048-X","volume":"14","author":"NH Greig","year":"1987","unstructured":"Greig NH: Optimizing drug delivery to brain tumors. Cancer Treat Rev 14: 1?28, 1987","journal-title":"Cancer Treat Rev"},{"key":"CR4","first-page":"257","volume-title":"Cancer Principles and Practice of Oncology","author":"VT DeVita Jr.","year":"1985","unstructured":"DeVita Jr. VT: Principles of Chemotherapy. In: DeVita VT, Hellman S and Rosenberg SA (eds) Cancer Principles and Practice of Oncology, 2nd edition. J.B. Lippincott, Philadelphia, 1985, pp 257?286","edition":"2nd edition"},{"key":"CR5","first-page":"68","volume":"48","author":"PA Andrews","year":"1988","unstructured":"Andrews PA, Velury S, Mann SC, Howell SB: cis-Diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48: 68?73, 1988","journal-title":"Cancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/283593a0","volume":"283","author":"BW Durkacz","year":"1980","unstructured":"Durkacz BW, Omidiji O, Gray DA, Shall S: (ADP-ribose)n participates in DNA excision repair. Nature 283: 593?596,1980.","journal-title":"Nature"},{"key":"CR7","first-page":"3911","volume":"47","author":"PJ O'Dwyer","year":"1987","unstructured":"O'Dwyer PJ, King SA, Hoth DF, Leyland-Jones B: Role of thymidine in biochemical modulation: a review. Cancer Res 47: 3911?3919, 1987","journal-title":"Cancer Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1432-1033.1980.tb04528.x","volume":"105","author":"N Nduka","year":"1980","unstructured":"Nduka N, Skidmore CJ, Shall S: The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly (ADP-ribose) polymerase. Eur J Biochem 105:525?530,1980","journal-title":"Eur J Biochem"},{"key":"CR9","first-page":"435","volume-title":"Basic Life Sciences, Vol. 31","author":"M Fox","year":"1985","unstructured":"Fox M: The effects of pyrimidine nucleotides on alkylating agent induced cytotoxicity and spontaneous and induced mutation to purine analog resistance in V79 cells. In: de Serres FJ, Sheridan W (eds) Basic Life Sciences, Vol. 31. Plenum Press, Inc., New York, NY, 1985, pp 435?451"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-12-565050-2.50008-5","volume-title":"Cisplatin: Current Status and New Developments","author":"B Drewinko","year":"1980","unstructured":"Drewinko B, Corry P, Bergerat JP, Barlogie B: The lethal activity of platinum compounds in combination with pyrimidine derivatives. In: Prestayko AW, Crooke ST, and Carter SK. (eds). Cisplatin: Current Status and New Developments. Academic Press, New York, 1980, pp 37?55"},{"key":"CR11","first-page":"580","volume":"55","author":"DW Kufe","year":"1980","unstructured":"Kufe DW, Beardsley P, Karp D, Parker L, Rosowsky A, Canellos G, Frei E III: High-dose thymidine infusions in patients with leukemia and lymphoma. Blood 55: 580?589, 1980","journal-title":"Blood"},{"key":"CR12","first-page":"1307","volume":"64","author":"DW Kufe","year":"1980","unstructured":"Kufe DW, Egan EM, Rosowsky A, Ensminger W, Frei E III: Thymidine arrest and synchrony of cellular growth in vivo. Cancer Treat Rep 64: 1307?1317, 1980","journal-title":"Cancer Treat Rep"},{"key":"CR13","first-page":"2203","volume":"4","author":"MS Blumenreich","year":"1984","unstructured":"Blumenreich MS, Woodcock TM, Andreeff M, Hiddemann W, Chou TC, Vale K, O'Hehir M, Clarkson BD, and Young CW: Effect of very high-dose thymidine infusions on leukemia and lymphoma patients. Cancer Res 4: 2203?2207, 1984","journal-title":"Cancer Res"},{"key":"CR14","first-page":"945","volume":"63","author":"DS Zaharko","year":"1979","unstructured":"Zaharko DS, Bolten BJ, Kobayashi T, Blasberg RG, Lee SS, Giovanella BC, Stehlin JS, Jr: Thymidine and thymine in biologic fluids during high-dose infusions of thymidine in mice, monkeys, and man. Cancer Treat Rep 63: 945?949, 1979","journal-title":"Cancer Treat Rep"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-2952(86)90560-5","volume":"35","author":"GE Adams","year":"1986","unstructured":"Adams GE and Stratford IJ. Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. Biochem Pharmacol 35: 71?76, 1986","journal-title":"Biochem Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0006-2952(86)90567-8","volume":"35","author":"DW Siemann","year":"1986","unstructured":"Siemann DW and Mulcahy RT. Sensitization of cancer chemotherapeutic agents by nitroheterocyclics. Biochem Pharmacol 35: 111?115, 1986","journal-title":"Biochem Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1227\/00006123-198109000-00021","volume":"9","author":"M Salcman","year":"1981","unstructured":"Salcman M, Samaras GM, and Eng P. Hyperthermia for brain tumors: Biophysical rationale. Neurosurgery 9: 327?335, 1981","journal-title":"Neurosurgery"},{"key":"CR18","first-page":"26","volume-title":"Hyperthermia in Cancer Treatment, Vol 3","author":"BE Lyons","year":"1986","unstructured":"Lyons BE, Strohbehn JW, Roberts DW: Interstitial microwave hyperthermia for the treatment of brain tumors. In: Anghileri LJ, Robert J (eds) Hyperthermia in Cancer Treatment, Vol 3. CRC Press Inc, Boca Raton, FL, 1986, pp 26?43"},{"key":"CR19","first-page":"550","volume":"94","author":"RG Selker","year":"1983","unstructured":"Selker RG, Jacobs SA, Stoller R, Kristofik M, and Randall M. On the limits of human tolerance to whole body hyperthermia and simultaneous chemotherapy. Radiation Res 94:550,1983","journal-title":"Radiation Res"},{"key":"CR20","first-page":"4335","volume":"47","author":"JD Cohen","year":"1987","unstructured":"Cohen JD and Robins HI: Hyperthermic enhancement of cis-diammine- 1,1-cyclobutane dicarboxylate platinum (II) cytotoxicity in human leukemia cells in vitro. Cancer Res 47:4335?4337,1987","journal-title":"Cancer Res"},{"key":"CR21","first-page":"3937","volume":"45","author":"HI Robins","year":"1985","unstructured":"Robins HI, Dennis WH, Neville AJ, Shecterle LM, Martin PA, Grossman J, Davis TE, Neville SR, Gillis WK, Rusy BF: A nontoxic system for 41.8\u00b0C whole body hyperthermia: results of a phase I study using a radiant heat device. Cancer Res 45: 3937?3944, 1985","journal-title":"Cancer Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1148\/123.2.475","volume":"123","author":"PM Corry","year":"1977","unstructured":"Corry PM, Robinson S, Getz SG: Hyperthermic effects on DNA repair mechanisms. Radiology 123: 475?482, 1977","journal-title":"Radiology"},{"key":"CR23","first-page":"3576","volume":"48","author":"JD Cohen","year":"1988","unstructured":"Cohen JD, Robins HI, Mulcahey RT, Gipp JJ, Bouck N: Interactions between hyperthermia and irradiation in two human lymphoblastic leukemia cell lines in vitro. Cancer Res 48: 3576?3580, 1988","journal-title":"Cancer Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/02656738609004965","volume":"2","author":"JE Riviere","year":"1986","unstructured":"Riviere JE, Page RL, Dewhirst MW, Tyczkowska K, Thrall DE: Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs. Int J Hyperthermia 2: 351?358, 1986","journal-title":"Int J Hyperthermia"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1200\/JCO.1987.5.10.1613","volume":"5","author":"EL Zakris","year":"1987","unstructured":"Zakris EL, Dewhirst MW, Riviere JE, Hoopes PJ, Page RL, Oleson JR: Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia. J Clin Oncol 5: 1613?1620, 1987","journal-title":"J Clin Oncol"},{"key":"CR26","first-page":"6242","volume":"46","author":"KE Wallner","year":"1986","unstructured":"Wallner KE, DeGregorio MW, Li GC: Hyperthermic potentiation of cis-diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res 46: 6242?6245, 1986","journal-title":"Cancer Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1986.168","volume":"54","author":"H Eichholtz-Wirth","year":"1986","unstructured":"Eichholtz-Wirth H, Hietel B: The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro. Br J Cancer 54: 239?243, 1986","journal-title":"Br J Cancer"},{"key":"CR28","first-page":"4038","volume":"47","author":"P Lane","year":"1987","unstructured":"Lane P, Vichi P, Bain DL, Tritton TR: Temperature dependence studies of adriamycin uptake and cytotoxicity. Cancer Res 47: 4038?42, 1987","journal-title":"Cancer Res"},{"key":"CR29","first-page":"1308","volume":"47","author":"KE Wallner","year":"1987","unstructured":"Wallner KE, Banda M, Li GC: Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Res 47: 1308?1312, 1987","journal-title":"Cancer Res"},{"key":"CR30","first-page":"3138","volume":"43","author":"DM Brown","year":"1983","unstructured":"Brown DM, Cohen MS, Sayerman RH: Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro. Cancer Res 43:3138?3142,1983","journal-title":"Cancer Res"},{"key":"CR31","first-page":"5537","volume":"47","author":"OS Frankfurt","year":"1987","unstructured":"Frankfurt OS: Flow cytometry analysis of DNA damage and the evaluation of cytotoxicity of alkylating agents. Cancer Res 47: 5537?5541, 1987","journal-title":"Cancer Res"},{"key":"CR32","first-page":"2474","volume":"42","author":"DJ Stewart","year":"1982","unstructured":"Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474?2479, 1982","journal-title":"Cancer Res"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/02656738709140387","volume":"3","author":"A Hugander","year":"1978","unstructured":"Hugander A, Robins HI, Martin P, Schmitt C: Temperature distribution during radiant heat whole-body hyperthermia: experimental studies in the dog. Int J Hyperthermia 3: 199?208, 1978","journal-title":"Int J Hyperthermia"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3835(89)90062-1","volume":"44","author":"JD Cohen","year":"1989","unstructured":"Cohen JD, Robins HI, Schmitt CL: Interactions of hyperthermia with carboplatin, cisplatin, and etoposide in human leukemia cells in vitro. Cancer Letters, 44: 205?210, 1989","journal-title":"Cancer Letters"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00254197","volume":"11","author":"H Gerad","year":"1983","unstructured":"Gerad H, Egorin MJ, Whitacre M, Van Echo DA, Aisner J: Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum (II) and whole body hyperthermia. Cancer Chemother Pharmacol 11: 162?166, 1983","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR36","first-page":"440","volume":"48","author":"J Wondergem","year":"1988","unstructured":"Wondergem J, Bulger RE, Strebel FR, Newman RA, Travis EL, Stephens, LC, Bull JMC: Effect of cis-diamminedichloroplatinum (II) combined with whole body hyperthermia on renal injury. Cancer Res 48: 440?446, 1988","journal-title":"Cancer Res"},{"key":"CR37","first-page":"61","volume":"5","author":"R Canetta","year":"1987","unstructured":"Canetta R, Franks C, Smaldone L, Bragman K, Rozencweig M: Clinical status of carboplatin. Oncology 5: 61?70, 1987","journal-title":"Oncology"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF00257742","volume":"9","author":"AH Calvert","year":"1982","unstructured":"Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, McElwain TJ, Raju S, Wiltshaw E, Smith IE, Baker JM, Peckham MJ, Harrap KR: Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9: 140?147, 1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR39","doi-asserted-by":"crossref","unstructured":"Nichols C, Williams S, Tricot G, Loehrer P, Akard L, Einhorn L, Jansen J: Phase I study of high dose VP-16 plus carboplatin (CBDCA) withautologous bone marrow rescue (ABMT) in refractory germ cell cancer. Proc American Society for Clinical Oncology 7: Abst 454, 1988","DOI":"10.1200\/JCO.1989.7.7.932"},{"key":"CR40","first-page":"6297","volume":"47","author":"MB Hennik van","year":"1987","unstructured":"van Hennik MB, van der Vijgh WJF, Klein I, Elferink F, Vermoken JB, Winograd B, Pinedo HM: Comparative pharmacokinetics of cisplatin and three analogues in mice and humans. Cancer Res 47: 6297?6301, 1987","journal-title":"Cancer Res"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S0317167100043468","volume":"8","author":"RN Auer","year":"1981","unstructured":"Auer RN, Del Maestro RF, Anderson R: A simple and reproducible experimental in vivo glioma model. Canad J Neurol Sci 8: 325?331, 1981","journal-title":"Canad J Neurol Sci"},{"key":"CR42","first-page":"1367","volume":"46","author":"AH Kaye","year":"1986","unstructured":"Kaye AH, Morstyn G, Gardner I, Pyke K. Development of a xenograft glioma model in mouse brain. Cancer Res 46: 1367?1373,1986","journal-title":"Cancer Res"},{"key":"CR43","volume-title":"A User's Guide to Computer Programs for the Analysis of Cellular Survival Data","author":"N Albright","year":"1988","unstructured":"Albright N: A User's Guide to Computer Programs for the Analysis of Cellular Survival Data. University of California Press, Berkeley, CA, 1988."},{"key":"CR44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2307\/3570945","volume":"13","author":"MM Elkind","year":"1960","unstructured":"Elkind MM and Sutton H: Radiation response of mammalian cells grown in culture. Radiation Res 13: 556?593,1960","journal-title":"Radiation Res"},{"key":"CR45","first-page":"401","volume":"29","author":"SS Lee","year":"1977","unstructured":"Lee SS, Giovanella BC, Stehlin JS: Selective lethal effect of thymidine on human and mouse tumor cells. J Cell Physiol 29:401?406,1977","journal-title":"J Cell Physiol"},{"key":"CR46","doi-asserted-by":"crossref","unstructured":"Reynolds EC, Harris AW, Finch LR: Deoxyribonucleoside triphosphate pools and differential thymidine sensitivities of cultured mouse lymphoma and myeloma cells. Biochim Biophys Acta 561?110, 1979","DOI":"10.1016\/0005-2787(79)90495-7"},{"key":"CR47","first-page":"3745","volume":"38","author":"K. Tsuboi","year":"1978","unstructured":"Tsuboi K. and Kwong L.K. Antiproliferative agents: differential survival between normal and cancer cells. Cancer 38: 3745?3750,1978","journal-title":"Cancer"},{"key":"CR48","first-page":"2928","volume":"39","author":"SS Lee","year":"1979","unstructured":"Lee SS, Giovanella BC, Stehlin JS, Brunn JC: Regression of human tumors established in nude mice after continuous infusion of thymidine. Cancer Res 39: 2928?2933, 1979","journal-title":"Cancer Res"},{"key":"CR49","first-page":"1797","volume":"45","author":"A Lockshin","year":"1985","unstructured":"Lockshin A, Giovanella BC, Stehlin JS Jr., Kozielski T, Quian C, Apperson RW: Antitumor activity and minimal toxicity of concentrated thymidine infused in nude mice. Cancer Res 45: 1797?1802, 1985","journal-title":"Cancer Res"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/1097-0142(19811001)48:7<1513::AID-CNCR2820480705>3.0.CO;2-Q","volume":"48","author":"DW Kufe","year":"1981","unstructured":"Kufe DW, Wick MM, Moschella S, Major P: Effect of high-dose thymidine infusions in patients with mycosis fungoides. Cancer 48: 1513?1516, 1981","journal-title":"Cancer"},{"key":"CR51","unstructured":"Tapazoglou E, Robins HI, Khatana A, Schmitt CL, Cohen J, Franken K, Corry P, Sapareto SA: Whole body hyperthermia (WBH) potentiation of carboplatin (CBDCA) cytotoxicity in murine AKR leukemia. Proc North American Hyperthermia Group, Abst Cd-13, 1988"},{"key":"CR52","unstructured":"Page RL, McEntee MC, Heidner GL, Riviere JE, Thrall DE: Phase I evaluation of carboplatin at 37 and 42\u00b0C in tumor bearing dogs. Proc North American Hyperthermia Group, Abst Bd-9, 1989"},{"key":"CR53","first-page":"4184","volume":"46","author":"RL Schilsky","year":"1986","unstructured":"Schilsky RL, O'Laughlin K, Ratain MJ: Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum (II) in patients with advanced cancer. Cancer Res 46: 4184?4188, 1986","journal-title":"Cancer Res"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1016\/S0021-9258(18)83741-3","volume":"264","author":"PW Rankin","year":"1989","unstructured":"Rankin PW, Jacobson EL, Benjamin RC, Moss J, Jacobson MK: Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J Biol Chem 264: 4312?4317,1989","journal-title":"J Biol Chem"},{"key":"CR55","unstructured":"Cohen JD, Schmitt CL, Robins HI, Javid MJ: The interaction of hyperthermia (HT), thymidine (TdR), and ionizing irradiation (XRT) in lymphoid neoplasms. Proc Radiation Research Society: Abst Af-13, 1989"},{"key":"CR56","unstructured":"Cohen JD, Robins HI, Schmitt CL: Interactions of hyperthermia (HT) and thymidine (TdR) with carboplatin (CBDCA) or ionizing irradiation (XRT) in glioblastoma cells. Proc Radiation Research Society: Abst Af-14, 1989"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00167062\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00167062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00167062\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00167062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T23:32:42Z","timestamp":1682811162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00167062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,8]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,8]]}},"alternative-id":["BF00167062"],"URL":"https:\/\/doi.org\/10.1007\/bf00167062","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,8]]}}}